Técnicas de evaluación para videojuegos geolocalizados

El presente TFG tiene como objetivo encontrar cuáles son los instrumentos y técnicas más adecuadas para evaluar los videojuegos geolocalizados con realidad aumentada. Para ello, se han estudiado los instrumentos de evaluación recomendados por los principales autores e investigadores de los campos de la usabilidad, experiencia de usuario, jugabilidad y experiencia del jugador. De estos instrumentos y técnicas, se seleccionaron los instrumentos y métodos más adecuados para este tipo de videojuegos. Finalmente, se ha tomado como caso de estudio la evaluación de Progrezz, una plataforma que permite gamificar acciones sociales reales, utilizando como soporte para ello tecnología móvil geolocalizada con realidad aumentada

PROVITAO: a research program based on active games for help the abulatory treatment of childhood obesity

Childhood obesity is the most prevalent chronic disease in developed and developing countries. Recent studies showed that the Canary Islands are the Spanish region with the highest rate of childhood obesity. However, this disease is easy to prevent, educating children from healthy habits, and, the ICT in general and videogames in particular, represent an opportunity to work towards change. Therefore, this paper presents the design of an educational intervention program to help the ambulatory treatment of childhood obesity. This program is intended for children 8 to 12 years of age with obesity and who come for the first time to the Pediatric Service of the University Hospital of Canaries, and is currently being validated. The partial results show that the satisfaction of the minors with the program is high, emphasizing the focus in games

Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it with antistaphylococcal penicillin (ASP). Methods: Prospective cohort study with retrospective analysis of a cohort of MSSA IE treated with cloxacillin and/or cefazolin. Outcomes assessed were relapse; intra-hospital, overall, and endocarditis-related mortality; and adverse events. Risk of renal toxicity with each treatment was evaluated separately. Results: We included 631 IE episodes caused by MSSA treated with cloxacillin and/or cefazolin. Antibiotic treatment was cloxacillin, cefazolin, or both in 537 (85%), 57 (9%), and 37 (6%) episodes, respectively. Patients treated with cefazolin had significantly higher rates of comorbidities (median Charlson Index 7, P <0.01) and previous renal failure (57.9%, P <0.01). Patients treated with cloxacillin presented higher rates of septic shock (25%, P = 0.033) and new-onset or worsening renal failure (47.3%, P = 0.024) with significantly higher rates of in-hospital mortality (38.5%, P = 0.017). One-year IE-related mortality and rate of relapses were similar between treatment groups. None of the treatments were identified as risk or protective factors. Conclusion: Our results suggest that cefazolin is a valuable option for the treatment of MSSA IE, without differences in 1-year mortality or relapses compared with cloxacillin, and might be considered equally effective